ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer
Condition: Extensive Stage Small Cell Lung Cancer (ES-SCLC) Intervention: Drug: HS-20093 Sponsor: Hansoh BioMedical R&D Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials